These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21549101)

  • 1. Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice.
    Adachi H; Kondo T; Koh GY; Nagy A; Oike Y; Araki E
    Biochem Biophys Res Commun; 2011 Jun; 409(2):177-80. PubMed ID: 21549101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes.
    Goldberg IJ; Hu Y; Noh HL; Wei J; Huggins LA; Rackmill MG; Hamai H; Reid BN; Blaner WS; Huang LS
    Diabetes; 2008 Jun; 57(6):1674-82. PubMed ID: 18346984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy.
    Hammad SM; Powell-Braxton L; Otvos JD; Eldridge L; Won W; Lyons TJ
    Metabolism; 2003 Jul; 52(7):916-21. PubMed ID: 12870170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance.
    Ng DS; Xie C; Maguire GF; Zhu X; Ugwu F; Lam E; Connelly PW
    J Biol Chem; 2004 Feb; 279(9):7636-42. PubMed ID: 14668345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y; Liu XQ; Rall SC; Mahley RW
    J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
    Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
    Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.
    Köster A; Chao YB; Mosior M; Ford A; Gonzalez-DeWhitt PA; Hale JE; Li D; Qiu Y; Fraser CC; Yang DD; Heuer JG; Jaskunas SR; Eacho P
    Endocrinology; 2005 Nov; 146(11):4943-50. PubMed ID: 16081640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic disorders of serum lipoproteins in endotoxin-poisoned mice: the role of high density lipoprotein (HDL) and triglyceride-rich lipoproteins.
    Sakaguchi S
    Microbiol Immunol; 1982; 26(11):1017-34. PubMed ID: 6220193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.
    Ruscica M; Zimetti F; Adorni MP; Sirtori CR; Lupo MG; Ferri N
    Pharmacol Res; 2020 Mar; 153():104653. PubMed ID: 31931117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
    Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
    Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of triglyceride metabolism by Angiopoietin-like proteins.
    Mattijssen F; Kersten S
    Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.
    Wang Y; Gusarova V; Banfi S; Gromada J; Cohen JC; Hobbs HH
    J Lipid Res; 2015 Jul; 56(7):1296-307. PubMed ID: 25954050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits.
    Mehta N; Qamar A; Qu L; Qasim AN; Mehta NN; Reilly MP; Rader DJ
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1057-63. PubMed ID: 24626437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake.
    Lichtenstein L; Berbée JF; van Dijk SJ; van Dijk KW; Bensadoun A; Kema IP; Voshol PJ; Müller M; Rensen PC; Kersten S
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2420-7. PubMed ID: 17761937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-Like Protein 4 Is a High-Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type-2 Diabetic Patients.
    Yang LY; Yu CG; Wang XH; Yuan SS; Zhang LJ; Lang JN; Zhao D; Feng YM
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr
    Al-Sharea A; Murphy AJ; Huggins LA; Hu Y; Goldberg IJ; Nagareddy PR
    Atherosclerosis; 2018 Apr; 271():166-176. PubMed ID: 29518749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.
    Jones C; Garuti R; Michaely P; Li WP; Maeda N; Cohen JC; Herz J; Hobbs HH
    J Clin Invest; 2007 Jan; 117(1):165-74. PubMed ID: 17200716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolemia and triglyceride metabolism.
    Kolovou GD; Kostakou PM; Anagnostopoulou KK
    Int J Cardiol; 2011 Mar; 147(3):349-58. PubMed ID: 20826022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.